Cargando…
Nebulized perflubron and carbon dioxide rapidly dilate constricted airways in an ovine model of allergic asthma
BACKGROUND: The low toxicity of perfluorocarbons (PFCs), their high affinity for respiratory gases and their compatibility with lung surfactant have made them useful candidates for treating respiratory diseases such as adult respiratory distress syndrome. We report results for treating acute allergi...
Autores principales: | El Mays, Tamer Y, Choudhury, Parichita, Leigh, Richard, Koumoundouros, Emmanuel, Van der Velden, Joanne, Shrestha, Grishma, Pieron, Cora A, Dennis, John H, Green, Francis HY, Snibson, Ken J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172894/ https://www.ncbi.nlm.nih.gov/pubmed/25355286 http://dx.doi.org/10.1186/s12931-014-0098-x |
Ejemplares similares
-
A phase I, placebo-controlled, randomized, double-blind, single ascending dose-ranging study to evaluate the safety and tolerability of a novel biophysical bronchodilator (S-1226) administered by nebulization in healthy volunteers
por: Green, Francis H. Y., et al.
Publicado: (2016) -
Increased Mast Cell Density and Airway Responses to Allergic and Non-Allergic Stimuli in a Sheep Model of Chronic Asthma
por: Van der Velden, Joanne, et al.
Publicado: (2012) -
Perflubron Distribution During Transition From Gas to Total Liquid Ventilation
por: Sage, Michaël, et al.
Publicado: (2018) -
Assessment of Peripheral Airway Function following Chronic Allergen Challenge in a Sheep Model of Asthma
por: Van der Velden, Joanne, et al.
Publicado: (2011) -
A phase IIa proof-of-concept, placebo-controlled, randomized, double-blind, crossover, single-dose clinical trial of a new class of bronchodilator for acute asthma
por: Swystun, Veronica, et al.
Publicado: (2018)